It does not seem to be convincing that a one-time measurement of the plasma BNP level at discharge in each HF patient can predict the day of occurrence of cardiovascular events because the BNP levels may fluctuate weekly or monthly during outpatient follow-up, despite the constant intake of medications. This evidence concerns the gene NPPB and hydrops fetalis.